The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways

• Published in: Scientific reports Vol. 7; no. 1; p. 42937
• Main Authors: García, Marta, Barrio, Raquel, García-Lavandeira, Montserrat, Garcia-Rendueles, Angela R, Escudero, Adela, Díaz-Rodríguez, Esther, Gorbenko Del Blanco, Darya, Fernández, Ana, de Rijke, Yolanda B, Vallespín, Elena, Nevado, Julián, Lapunzina, Pablo, Matre, Vilborg, Hinkle, Patricia M, Hokken-Koelega, Anita C S, de Miguel, María P, Cameselle-Teijeiro, José Manuel, Nistal, Manuel, Alvarez, Clara V, Moreno, José C
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 06.03.2017
• Subjects: Activins - metabolism; Animals; DNA Mutational Analysis; Follicle Stimulating Hormone, beta Subunit - genetics; Follicle Stimulating Hormone, beta Subunit - metabolism; Follow-Up Studies; Gene Deletion; Humans; Hypothyroidism - genetics; Hypothyroidism - pathology; Immunoglobulins - genetics; Infant, Newborn; Male; Membrane Proteins - genetics; Mice; Pituitary Gland - metabolism; Pituitary Gland - pathology; Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Thyrotropin-Releasing Hormone - genetics; Receptors, Thyrotropin-Releasing Hormone - metabolism; Smad Proteins - metabolism; Testis - metabolism; Testis - pathology; Transforming Growth Factor beta - metabolism
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep42937

IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism. However, the pathogenic mechanisms of the disease remain unclear. Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion. The patient showed congenital central hypothyroidism with reduced TSH biopotency, over-secretion of FSH at neonatal minipuberty and macroorchidism from 3 years of age. His markedly elevated inhibin B was unable to inhibit FSH secretion, indicating a status of pituitary inhibin B resistance. We show here that IGSF1 is expressed both in thyrotropes and gonadotropes of the pituitary and in Leydig and germ cells in the testes, but at very low levels in Sertoli cells. Furthermore, IGSF1 stimulates transcription of the thyrotropin-releasing hormone receptor (TRHR) by negative modulation of the TGFβ1-Smad signaling pathway, and enhances the synthesis and biopotency of TSH, the hormone secreted by thyrotropes. By contrast, IGSF1 strongly down-regulates the activin-Smad pathway, leading to reduced expression of FSHB, the hormone secreted by gonadotropes. In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGFβ/Activin pathways in the pituitary.